New York Cancer & Blood Specialists - Port Jeffers,49 Rte. 347, Newconset Hwy — Port Jefferson Station, New York

New York Cancer & Blood Specialists - Port Jeffers,49 Rte. 347, Newconset Hwy is a clinical research site located in Port Jefferson Station, New York, United States 11776.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

New York Cancer & Blood Specialists - Port Jeffers,49 Rte. 347, Newconset Hwy has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Triple Negative Breast Cancer, PD-L1 Negative, PD-L1 Positive.

Sponsors: Gilead Sciences.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Cancer & Blood Specialists - Port Jeffers,49 Rte. 347, Newconset Hwy?

New York Cancer & Blood Specialists - Port Jeffers,49 Rte. 347, Newconset Hwy has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Cancer & Blood Specialists - Port Jeffers,49 Rte. 347, Newconset Hwy conducted?

New York Cancer & Blood Specialists - Port Jeffers,49 Rte. 347, Newconset Hwy has 2 clinical trials on record, with 2 currently active. Their work covers Triple Negative Breast Cancer, PD-L1 Negative, PD-L1 Positive.

Is New York Cancer & Blood Specialists - Port Jeffers,49 Rte. 347, Newconset Hwy accredited by Crixeo Health?

New York Cancer & Blood Specialists - Port Jeffers,49 Rte. 347, Newconset Hwy has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York Cancer & Blood Specialists - Port Jeffers,49 Rte. 347, Newconset Hwy?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.